Comparing H-CYTE (OTCMKTS:HCYTD) and Assure (OTCMKTS:IONM)

Volatility & Risk

H-CYTE has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Comparatively, Assure has a beta of 217.15, suggesting that its stock price is 21,615% more volatile than the S&P 500.

Insider & Institutional Ownership

3.3% of Assure shares are owned by institutional investors. 5.2% of H-CYTE shares are owned by company insiders. Comparatively, 3.8% of Assure shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares H-CYTE and Assure”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
H-CYTE $1.61 million 0.32 -$4.80 million N/A N/A
Assure $250,000.00 0.01 -$26.08 million ($56.12) 0.00

H-CYTE has higher revenue and earnings than Assure.

Profitability

This table compares H-CYTE and Assure’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
H-CYTE -450.40% N/A -777.68%
Assure N/A N/A N/A

About H-CYTE

(Get Free Report)

H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

About Assure

(Get Free Report)

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. Assure Holdings Corp. is based in Englewood, Colorado.

Receive News & Ratings for H-CYTE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H-CYTE and related companies with MarketBeat.com's FREE daily email newsletter.